Literature DB >> 8787159

Diagnostic accuracy of Alzheimer's disease: a clinicopathological study.

K A Jellinger1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8787159     DOI： 10.1007/s004010050418

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  10 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.

Authors:  M C Tierney; R H Fisher; A J Lewis; M L Zorzitto; W G Snow; D W Reid; P Nieuwstraten
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

4.  Interlaboratory comparison of neuropathology assessment in Alzheimer's disease.

Authors:  K A Jellinger; C Bancher; P Fischer
Journal:  J Neuropathol Exp Neurol       Date:  1995-01       Impact factor: 3.685

5.  Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

Authors:  C Bancher; H Braak; P Fischer; K A Jellinger
Journal:  Neurosci Lett       Date:  1993-11-12       Impact factor: 3.046

6.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias.

Authors:  D Galasko; L A Hansen; R Katzman; W Wiederholt; E Masliah; R Terry; L R Hill; P Lessin; L J Thal
Journal:  Arch Neurol       Date:  1994-09

8.  Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa.

Authors:  L A Hansen; E Masliah; D Galasko; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease.

Authors:  M Gearing; S S Mirra; J C Hedreen; S M Sumi; L A Hansen; A Heyman
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

Review 10.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088
  10 in total
  13 in total

Review 1.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

Review 2.  Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Authors:  Anders Lönneborg
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

3.  Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

Authors:  E Tarkowski; K Blennow; A Wallin; A Tarkowski
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 4.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Authors:  Kaj Blennow; Harald Hampel; Michael Weiner; Henrik Zetterberg
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

5.  Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.

Authors:  Wei Tang; Qiong Huang; Yu-You Yao; Yan Wang; Yi-Le Wu; Zheng-Yu Wang
Journal:  J Neural Transm (Vienna)       Date:  2014-05-10       Impact factor: 3.575

Review 6.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

7.  CSF Biomarkers Profile in CADASIL-A Model of Pure Vascular Dementia: Usefulness in Differential Diagnosis in the Dementia Disorder.

Authors:  Patrizia Formichi; Lucilla Parnetti; Elena Radi; Gabriele Cevenini; Maria Teresa Dotti; Antonio Federico
Journal:  Int J Alzheimers Dis       Date:  2010-08-18

8.  [Dementia-current knowledge and significance for ENT specialists].

Authors:  C Schwemmle; U Schwemmle; N Buller; M Ptok
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

9.  Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia.

Authors:  Sabrina Ravaglia; Paola Bini; Elena Sinforiani; Diego Franciotta; Elisabetta Zardini; Pietro Tosca; Arrigo Moglia; Alfredo Costa
Journal:  Neurol Sci       Date:  2008-11-14       Impact factor: 3.307

Review 10.  Fluid biomarkers in Alzheimer disease.

Authors:  Kaj Blennow; Henrik Zetterberg; Anne M Fagan
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.